Bayer's Yaz Ads 'Misleading:' FDA

Law360, New York (October 8, 2008, 12:00 AM EDT) -- The U.S. Food and Drug Administration has chastised Bayer AG over two television commercials for Yaz, saying the ads over-promise the birth control pill's benefits and downplay serious risks associated with the drug.

These alleged violations are concerning from a public health perspective because they encourage the use of Yaz in circumstances other than those for which the drug has been approved, the agency told Bayer's president and chief executive officer Reinhard Franzen in an Oct. 3 letter, which the FDA posted on its Web site...
To view the full article, register now.